HanchorBio Tests Broader Ambitions for HCB101 Through InxMed Partnership
Taiwan-listed biotech looks to expand the value of its lead oncology asset through combination research with late-stage cancer drug resistance specialist InxMed. TAIPEI and SHANGHAI and SAN FRANCISCO, July 9, 2026 /PRNewswire/ -- HanchorBio, Inc....
Hanwha Power Signs Strategic Memorandum of Understanding with Canadian Energy Company Pembina Pipeline for Lower-Carbon Power Generation Business
Strategic cooperation is pursued as part of the ITB program linked to the Hanwha Ocean Canada Submarine Program(CPSP) Power generation from waste heat discarded by pipeline boosters, establishing a carbon-reduction solution for North American energy...